#Patient identifier	Cohort	Overall survival status	Overall survival months	Age	Gender	Smoking status	Stage	Adenocarcinoma subtype WHO2015	Histological grade
#Patient identifier	Cohort	Overall survival status	Overall survival months	Age	Gender	Smoking status	Stage	Adenocarcinoma subtype WHO2015	Histological grade
#STRING	STRING	STRING	NUMBER	NUMBER	STRING	STRING	STRING	STRING	STRING
#1	1	1	1	1	1	1	1	1	1
PATIENT_ID	COHORT	OS_STATUS	OS_MONTHS	AGE	GENDER	SMOKING_STATUS	STAGE	ADENOCARCINOMA_SUBTYPE_WHO2015	HISTOLOGICAL_GRADE
BGI-EX01	BGI	LIVING	20	59	Male	Yes	III	Adenocarcinoma	NA
BGI-EX02	BGI	LIVING	13	45	Male	No	III	Adenocarcinoma	NA
BGI-EX03	BGI	LIVING	12	60	Male	Yes	III	Adenocarcinoma	NA
BGI-EX04	BGI	LIVING	6	67	Female	No	III	Adenocarcinoma	NA
BGI-EX05	BGI	DECEASED	4	68	Male	Yes	III	Adenocarcinoma	NA
BGI-EX06	BGI	LIVING	17	82	Male	Yes	I	Adenocarcinoma	NA
BGI-EX07	BGI	LIVING	17	51	Male	Yes	II	Adenocarcinoma	NA
BGI-EX08	BGI	LIVING	16	47	Male	Yes	IV	Adenocarcinoma	NA
BGI-EX09	BGI	DECEASED	13	52	Male	Yes	III	Adenocarcinoma	NA
BGI-RS01	BGI	DECEASED	37	57	Male	No	III	Adenocarcinoma	NA
BGI-RS02	BGI	DECEASED	23	58	Female	No	III	Adenocarcinoma	NA
BGI-RS03	BGI	LIVING	67	50	Male	Yes	III	Adenocarcinoma	NA
BGI-RS04	BGI	DECEASED	50	54	Male	Yes	III	Adenocarcinoma	NA
BGI-RS05	BGI	DECEASED	26	71	Male	Yes	III	Adenocarcinoma	NA
BGI-RS06	BGI	LIVING	59	56	Male	Yes	III	Adenocarcinoma	NA
BGI-RS07	BGI	DECEASED	6	72	Male	No	III	Adenocarcinoma	NA
BGI-RS08	BGI	LIVING	65	66	Female	No	III	Adenocarcinoma	NA
BGI-RS09	BGI	DECEASED	12	57	Female	No	IV	Adenocarcinoma	NA
BGI-RS10	BGI	DECEASED	20	51	Male	No	III	Adenocarcinoma	NA
BGI-RS11	BGI	LIVING	61	60	Female	No	III	Adenocarcinoma	NA
BGI-RS12	BGI	LIVING	66	59	Female	No	III	Adenocarcinoma	NA
BGI-RS13	BGI	DECEASED	29	67	Male	No	IV	Adenocarcinoma	NA
BGI-RS14	BGI	DECEASED	60	55	Male	Yes	III	Adenocarcinoma	NA
BGI-RS15	BGI	DECEASED	41	64	Male	No	III	Adenocarcinoma	NA
BGI-RS16	BGI	LIVING	78	56	Female	No	III	Adenocarcinoma	NA
BGI-RS17	BGI	LIVING	47	53	Female	No	III	Adenocarcinoma	NA
BGI-RS18	BGI	DECEASED	NA	62	Male	Yes	III	Adenocarcinoma	NA
BGI-RS19	BGI	LIVING	67	53	Male	Yes	I	Adenocarcinoma	NA
BGI-RS20	BGI	DECEASED	12	42	Female	No	III	Adenocarcinoma	NA
BGI-RS21	BGI	LIVING	61	67	Female	No	III	Adenocarcinoma	NA
BGI-RS22	BGI	DECEASED	24	62	Male	No	IV	Adenocarcinoma	NA
BGI-RS23	BGI	LIVING	80	70	Male	No	III	Adenocarcinoma	NA
BGI-RS24	BGI	LIVING	55	53	Male	NA	II	Adenocarcinoma	NA
BGI-RS25	BGI	DECEASED	22	59	Female	No	III	Adenocarcinoma	NA
BGI-RS26	BGI	LIVING	59	68	Male	Yes	III	Adenocarcinoma	NA
BGI-RS27	BGI	DECEASED	20	70	Male	No	III	Adenocarcinoma	NA
BGI-RS28	BGI	DECEASED	32	62	Male	No	I	Adenocarcinoma	NA
BGI-RS29	BGI	LIVING	54	57	Female	No	I	Adenocarcinoma	NA
BGI-RS30	BGI	DECEASED	59	61	Male	Yes	I	Adenocarcinoma	NA
BGI-RS31	BGI	DECEASED	28	63	Male	Yes	I	Adenocarcinoma	NA
BGI-RS32	BGI	DECEASED	17	67	Female	No	I	Adenocarcinoma	NA
BGI-RS33	BGI	DECEASED	6	67	Male	Yes	I	Adenocarcinoma	NA
BGI-RS34	BGI	DECEASED	55	74	Male	Yes	I	Adenocarcinoma	NA
BGI-RS35	BGI	DECEASED	49	72	Male	No	I	Adenocarcinoma	NA
BGI-RS36	BGI	LIVING	61	63	Male	Yes	II	Adenocarcinoma	NA
BGI-RS37	BGI	LIVING	56	54	Female	No	I	Adenocarcinoma	NA
BGI-RS38	BGI	LIVING	62	58	Male	Yes	II	Adenocarcinoma	NA
BGI-RS39	BGI	DECEASED	45	55	Female	No	II	Adenocarcinoma	NA
BGI-RS40	BGI	LIVING	22	41	Male	No	II	Adenocarcinoma	NA
BGI-RS41	BGI	LIVING	70	49	Female	No	I	Adenocarcinoma	NA
BGI-RS42	BGI	LIVING	63	46	Male	Yes	I	Adenocarcinoma	NA
BGI-RS44	BGI	LIVING	58	67	Male	Yes	I	Adenocarcinoma	NA
BGI-RS45	BGI	DECEASED	28	77	Female	No	III	Adenocarcinoma	NA
BGI-RS46	BGI	DECEASED	58	68	Male	No	II	Adenocarcinoma	NA
BGI-RS47	BGI	LIVING	56	49	Female	No	II	Adenocarcinoma	NA
BGI-RS48	BGI	DECEASED	NA	36	Male	No	II	Adenocarcinoma	NA
BGI-RS49	BGI	LIVING	61	51	Male	Yes	II	Adenocarcinoma	NA
BGI-RS50	BGI	DECEASED	5	65	Male	No	II	Adenocarcinoma	NA
BGI-RS51	BGI	LIVING	35	49	Male	Yes	III	Adenocarcinoma	NA
BGI-RS52	BGI	LIVING	48	57	Female	No	II	Adenocarcinoma	NA
BGI-RS53	BGI	LIVING	74	72	Female	No	I	Adenocarcinoma	NA
BGI-RS54	BGI	LIVING	49	67	Male	Yes	II	Adenocarcinoma	NA
BGI-RS55	BGI	LIVING	57	63	Male	No	II	Adenocarcinoma	NA
BGI-RS56	BGI	LIVING	58	62	Male	No	II	Adenocarcinoma	NA
BGI-RS57	BGI	DECEASED	10	71	Male	Yes	II	Adenocarcinoma	NA
BGI-RS58	BGI	LIVING	60	78	Female	Yes	I	Adenocarcinoma	NA
BGI-RS59	BGI	NA	NA	74	Male	No	II	Adenocarcinoma	NA
BGI-RS60	BGI	LIVING	62	60	Male	Yes	I	Adenocarcinoma	NA
BGI-WG01	BGI	DECEASED	4	77	Male	NA	III	Adenocarcinoma	NA
BGI-WG02	BGI	DECEASED	6	78	Male	Yes	III	Adenocarcinoma	NA
BGI-WG03	BGI	LIVING	16	56	Male	No	III	Adenocarcinoma	NA
BGI-WG04	BGI	LIVING	17	25	Female	No	IV	Adenocarcinoma	NA
BGI-WG05	BGI	LIVING	14	58	Male	NA	III	Adenocarcinoma	NA
BGI-WG06	BGI	LIVING	13	48	Female	No	III	Adenocarcinoma	NA
BGI-WG07	BGI	LIVING	15	55	Female	NA	III	Adenocarcinoma	NA
BGI-WG08	BGI	LIVING	16	63	Male	Yes	III	Adenocarcinoma	NA
BGI-WG09	BGI	LIVING	16	66	Male	Yes	III	Adenocarcinoma	NA
BGI-WG10	BGI	LIVING	15	65	Male	Yes	III	Adenocarcinoma	NA
BGI-WG11	BGI	LIVING	16	68	Female	No	III	Adenocarcinoma	NA
BGI-WG12	BGI	LIVING	13	57	Female	No	III	Adenocarcinoma	NA
BGI-WG13	BGI	LIVING	13	70	Female	No	III	Adenocarcinoma	NA
BGI-WG14	BGI	LIVING	5	59	Male	No	III	Adenocarcinoma	NA
BGI-WG15	BGI	LIVING	7	56	Female	Yes	III	Adenocarcinoma	NA
BGI-WG16	BGI	LIVING	5	41	Female	No	III	Adenocarcinoma	NA
BGI-WG17	BGI	LIVING	8	51	Male	No	III	Adenocarcinoma	NA
BGI-WG18	BGI	LIVING	7	65	Female	No	III	Adenocarcinoma	NA
BGI-WG19	BGI	LIVING	8	61	Female	No	III	Adenocarcinoma	NA
BGI-WG20	BGI	LIVING	7	62	Male	No	III	Adenocarcinoma	NA
BGI-WG21	BGI	LIVING	6	41	Female	No	II	Adenocarcinoma	NA
BGI-WG22	BGI	LIVING	24	34	Female	No	III	Adenocarcinoma	NA
BGI-WG23	BGI	LIVING	16	73	Male	No	III	Adenocarcinoma	NA
BGI-WG24	BGI	LIVING	17	67	Male	Yes	IV	Adenocarcinoma	NA
A183	GSK	DECEASED	70.63333333	75	Male	Yes	II	Adenocarcinoma	Moderately differentiated
A184	GSK	DECEASED	9.133333333	67	Female	No	III	Adenocarcinoma	Poorly differentiated
A185	GSK	DECEASED	1.8	59	Female	No	III	Adenocarcinoma	NA
A186	GSK	DECEASED	47.46666667	80	Female	No	I	Adenocarcinoma	Moderately differentiated
A187	GSK	DECEASED	12.5	38	Female	Yes	III	Adenocarcinoma	Moderately differentiated
A188	GSK	DECEASED	5.166666667	57	Female	No	I	Adenocarcinoma	Moderately differentiated
A190	GSK	DECEASED	35.33333333	65	Female	No	II	Adenocarcinoma	Moderately differentiated
A191	GSK	DECEASED	36.06666667	62	Male	No	I	Adenocarcinoma	Moderately differentiated
A192	GSK	DECEASED	38.76666667	84	Female	No	III	Adenocarcinoma	Moderately differentiated
A193	GSK	DECEASED	21.8	54	Male	Yes	I	Adenocarcinoma	Poorly differentiated
A194	GSK	DECEASED	34.4	54	Female	No	IV	Adenocarcinoma	Well differentiated
A195	GSK	DECEASED	23	62	Male	Yes	II	Adenocarcinoma	NA
A196	GSK	DECEASED	9.966666667	82	Male	Yes	II	Adenocarcinoma	Well to Moderately differentiated
A197	GSK	DECEASED	31.66666667	52	Male	Yes	I	Adenocarcinoma	Moderately differentiated
A198	GSK	DECEASED	14.86666667	67	Male	Yes	III	Adenocarcinoma	NA
A199	GSK	DECEASED	30.33333333	69	Male	Yes	I	Adenocarcinoma	Moderately differentiated
A200	GSK	LIVING	100.5666667	49	Male	Yes	III	Adenocarcinoma	Moderately differentiated
A201	GSK	LIVING	122.9	67	Female	Yes	II	Adenocarcinoma	Moderately differentiated
A202	GSK	LIVING	122.7	73	Female	No	I	Adenocarcinoma	Well differentiated
A203	GSK	LIVING	121.9666667	55	Male	No	II	Adenocarcinoma	Well differentiated
A204	GSK	LIVING	116.4333333	70	Female	No	III	Adenocarcinoma	Moderately differentiated
A205	GSK	DECEASED	91.03333333	79	Female	No	I	Adenocarcinoma	Moderately differentiated
A206	GSK	LIVING	112.1	78	Male	No	I	Adenocarcinoma	Moderately differentiated
A207	GSK	LIVING	111.3666667	59	Female	No	I	Adenocarcinoma	Well differentiated
A208	GSK	LIVING	110.5666667	77	Male	Yes	I	Adenocarcinoma	Moderately differentiated
A209	GSK	LIVING	57.73333333	62	Male	No	I	Adenocarcinoma	Well differentiated
A210	GSK	LIVING	105.3	50	Male	Yes	I	Adenocarcinoma	Poorly differentiated
A211	GSK	LIVING	108	50	Female	Yes	I	Adenocarcinoma	Moderately differentiated
A212	GSK	LIVING	108.4666667	68	Female	No	I	Adenocarcinoma	Moderately differentiated
A213	GSK	LIVING	102.2	76	Male	Yes	I	Adenocarcinoma	Well differentiated
A214	GSK	LIVING	101.9	58	Male	Yes	I	Adenocarcinoma	Poorly differentiated
A215	GSK	LIVING	103.5333333	54	Female	No	I	Adenocarcinoma	Well differentiated
A216	GSK	LIVING	104.9333333	61	Male	Yes	III	Adenocarcinoma	Moderately differentiated
A217	GSK	LIVING	104.2666667	71	Male	No	III	Adenocarcinoma	Well differentiated
A218	GSK	LIVING	75.73333333	67	Male	Yes	III	Adenocarcinoma	Poorly differentiated
A219	GSK	LIVING	97.03333333	52	Female	No	II	Adenocarcinoma	Moderately differentiated
A220	GSK	LIVING	98.56666667	60	Female	Yes	I	Adenocarcinoma	Moderately differentiated
A221	GSK	LIVING	95.16666667	72	Female	No	I	Adenocarcinoma	Moderately differentiated
A222	GSK	LIVING	94.76666667	61	Female	No	I	Adenocarcinoma	Moderately differentiated
A224	GSK	DECEASED	26.6	68	Male	No	III	Adenocarcinoma	NA
A227	GSK	DECEASED	6.366666667	75	Male	Yes	III	Adenocarcinoma	NA
A228	GSK	DECEASED	1.633333333	66	Male	Yes	IV	Adenocarcinoma	NA
A229	GSK	DECEASED	0.833333333	75	Male	Yes	IV	Adenocarcinoma	NA
A230	GSK	DECEASED	0.7	68	Male	Yes	IV	Adenocarcinoma	Moderately differentiated
A231	GSK	DECEASED	47.96666667	71	Male	Yes	II	Adenocarcinoma	NA
A232	GSK	DECEASED	30.8	76	Male	Yes	III	Adenocarcinoma	Moderately differentiated
A247	GSK	LIVING	26.16666667	69	Male	Yes	I	Adenocarcinoma	Poorly differentiated
A241	GSK	LIVING	34.16666667	70	Female	No	I	Adenocarcinoma	Moderately to Poorly differentiated
A234	GSK	LIVING	36.26666667	77	Male	Yes	I	Adenocarcinoma	Moderately differentiated
A233	GSK	LIVING	32.9	81	Male	No	I	Adenocarcinoma	Well to Moderately differentiated
A177	GSK	LIVING	34.5	77	Male	Yes	I	Adenocarcinoma	Poorly differentiated
A167	GSK	LIVING	35.36666667	74	Male	Yes	I	Adenocarcinoma	Moderately differentiated
A159	GSK	LIVING	37.3	49	Male	Yes	I	Adenocarcinoma	Moderately differentiated
A158	GSK	LIVING	38.93333333	63	Male	Yes	II	Adenocarcinoma	Moderately differentiated
A155	GSK	LIVING	37.66666667	66	Male	Yes	II	Adenocarcinoma	Moderately differentiated
A153	GSK	LIVING	39.03333333	78	Male	No	I	Adenocarcinoma	Moderately differentiated
A144	GSK	DECEASED	25.76666667	74	Male	No	II	Adenocarcinoma	Poorly differentiated
A143	GSK	DECEASED	5.533333333	68	Male	Yes	IV	Adenocarcinoma	Poorly differentiated
A139	GSK	DECEASED	5.066666667	76	Female	No	I	Adenocarcinoma	Moderately differentiated
A138	GSK	DECEASED	54	53	Female	No	III	Adenocarcinoma	Moderately differentiated
A131	GSK	DECEASED	35.8	69	Male	Yes	III	Adenocarcinoma	NA
A120	GSK	LIVING	46.63333333	82	Male	No	I	Adenocarcinoma	NA
A006	GSK	LIVING	61.6	56	Female	No	I	Adenocarcinoma	Moderately differentiated
A073	GSK	LIVING	50.2	51	Male	No	I	Adenocarcinoma	Moderately differentiated
A025	GSK	DECEASED	53.1	76	Male	Yes	II	Adenocarcinoma	NA
A016	GSK	LIVING	52.46666667	78	Male	Yes	I	Adenocarcinoma	Poorly differentiated
A012	GSK	LIVING	58.26666667	69	Male	Yes	I	Adenocarcinoma	Moderately to Poorly differentiated
A008	GSK	DECEASED	23.1	56	Female	No	III	Adenocarcinoma	Moderately differentiated
A258	GSK	DECEASED	24.53333333	65	Male	Yes	II	Adenocarcinoma	Moderately differentiated
A259	GSK	LIVING	87.46666667	37	Female	No	III	Adenocarcinoma	Moderately differentiated
A260	GSK	DECEASED	42	61	Female	No	I	Adenocarcinoma	NA
A261	GSK	DECEASED	46.26666667	45	Male	Yes	I	Adenocarcinoma	NA
A262	GSK	LIVING	61.5	64	Female	No	II	Adenocarcinoma	Moderately differentiated
A263	GSK	LIVING	89.8	64	Male	Yes	I	Adenocarcinoma	Moderately differentiated
A264	GSK	LIVING	68.93333333	58	Male	Yes	II	Adenocarcinoma	Poorly differentiated
A265	GSK	LIVING	1.5	65	Female	Yes	I	Adenocarcinoma	NA
A266	GSK	LIVING	36.9	63	Female	No	II	Adenocarcinoma	Poorly differentiated
A267	GSK	LIVING	70.03333333	72	Female	Yes	I	Adenocarcinoma	NA
A268	GSK	LIVING	65.86666667	70	Female	No	I	Adenocarcinoma	Well to Moderately differentiated
A269	GSK	LIVING	64.1	66	Female	No	I	Adenocarcinoma	Moderately differentiated
A270	GSK	LIVING	61.46666667	62	Female	No	I	Adenocarcinoma	Moderately differentiated
A271	GSK	LIVING	58.53333333	70	Male	Yes	I	Adenocarcinoma	Moderately differentiated
A272	GSK	LIVING	53.63333333	43	Female	No	I	Adenocarcinoma	Moderately differentiated
A273	GSK	LIVING	86.13333333	64	Female	No	I	Adenocarcinoma	Moderately differentiated
A274	GSK	LIVING	86.26666667	44	Female	No	I	Adenocarcinoma	Well differentiated
A275	GSK	LIVING	84.43333333	55	Female	No	II	Adenocarcinoma	Moderately differentiated
A276	GSK	DECEASED	80	71	Male	No	III	Adenocarcinoma	Moderately differentiated
A277	GSK	LIVING	83.76666667	70	Female	No	II	Adenocarcinoma	NA
A278	GSK	LIVING	82.83333333	73	Female	No	I	Adenocarcinoma	NA
A279	GSK	LIVING	78.83333333	59	Male	Yes	I	Adenocarcinoma	NA
A280	GSK	LIVING	74.86666667	49	Male	Yes	I	Adenocarcinoma	NA
A281	GSK	LIVING	69.1	66	Male	No	I	Adenocarcinoma	NA
A282	GSK	LIVING	69.2	72	Female	No	II	Adenocarcinoma	Moderately differentiated
A283	GSK	LIVING	67.26666667	67	Female	No	I	Adenocarcinoma	Moderately differentiated
A284	GSK	LIVING	68.8	58	Female	No	II	Adenocarcinoma	Moderately differentiated
A285	GSK	LIVING	66.8	64	Female	No	I	Adenocarcinoma	NA
A344	GSK	DECEASED	5.233333333	60	Male	Yes	IV	Adenocarcinoma	NA
A349	GSK	DECEASED	17.2	74	Male	Yes	IV	Adenocarcinoma	NA
A364	GSK	DECEASED	27.76666667	79	Female	No	IV	Adenocarcinoma	Moderately differentiated
A368	GSK	DECEASED	29.6	60	Female	No	IV	Adenocarcinoma	NA
A017	GSK	LIVING	53.46666667	52	Female	No	II	Adenocarcinoma	NA
A028	GSK	LIVING	56.7	75	Male	No	I	Adenocarcinoma	Moderately differentiated
A021	GSK	LIVING	54.73333333	57	Female	No	I	Adenocarcinoma	Moderately differentiated
A033	GSK	LIVING	50.9	44	Female	No	II	Adenocarcinoma	Poorly differentiated
A027	GSK	LIVING	50.93333333	58	Female	No	I	Adenocarcinoma	Moderately differentiated
A068	GSK	LIVING	51	79	Female	No	I	Adenocarcinoma	Poorly differentiated
A101	GSK	LIVING	51.26666667	58	Female	No	I	Adenocarcinoma	Moderately differentiated
A071	GSK	LIVING	52.36666667	76	Female	No	I	Adenocarcinoma	NA
A072	GSK	LIVING	49.93333333	60	Female	No	I	Adenocarcinoma	Moderately differentiated
A074	GSK	DECEASED	20.06666667	78	Female	No	IV	Adenocarcinoma	Poorly differentiated
A100	GSK	LIVING	47.23333333	73	Female	No	I	Adenocarcinoma	Well differentiated
A102	GSK	LIVING	51.3	73	Male	No	I	Adenocarcinoma	Moderately differentiated
A103	GSK	LIVING	50.3	63	Female	Yes	I	Adenocarcinoma	Moderately differentiated
A104	GSK	LIVING	46.3	70	Male	No	I	Adenocarcinoma	Moderately differentiated
A109	GSK	DECEASED	33.7	79	Male	Yes	I	Adenocarcinoma	Moderately to Poorly differentiated
A117	GSK	LIVING	49.96666667	64	Female	No	I	Adenocarcinoma	Moderately differentiated
A122	GSK	LIVING	46.86666667	63	Male	No	II	Adenocarcinoma	Moderately differentiated
A134	GSK	LIVING	44.6	52	Female	No	I	Adenocarcinoma	Moderately differentiated
A136	GSK	LIVING	41.96666667	72	Female	No	I	Adenocarcinoma	NA
A147	GSK	LIVING	43	57	Male	Yes	III	Adenocarcinoma	Moderately differentiated
A146	GSK	DECEASED	35.06666667	73	Male	No	II	Adenocarcinoma	Moderately differentiated
A148	GSK	LIVING	40.36666667	57	Male	Yes	III	Adenocarcinoma	Moderately differentiated
A149	GSK	LIVING	39.46666667	76	Male	No	I	Adenocarcinoma	Well differentiated
A150	GSK	LIVING	34.73333333	48	Male	Yes	I	Adenocarcinoma	Moderately differentiated
A156	GSK	LIVING	37.7	61	Female	No	I	Adenocarcinoma	Moderately differentiated
A165	GSK	LIVING	36.4	44	Female	No	I	Adenocarcinoma	Moderately differentiated
A157	GSK	LIVING	34.93333333	74	Male	Yes	I	Adenocarcinoma	Moderately to Poorly differentiated
A162	GSK	LIVING	31.43333333	67	Male	No	III	Adenocarcinoma	Moderately differentiated
A163	GSK	LIVING	9.433333333	57	Female	No	III	Adenocarcinoma	Moderately differentiated
A243	GSK	LIVING	33.8	62	Female	No	III	Adenocarcinoma	Poorly differentiated
A182	GSK	LIVING	34.2	72	Female	No	I	Adenocarcinoma	Poorly differentiated
A255	GSK	DECEASED	25.3	63	Male	No	I	Adenocarcinoma	Moderately differentiated
A169	GSK	LIVING	34.66666667	76	Female	Yes	NA	Adenocarcinoma	Moderately differentiated
A252	GSK	LIVING	33.16666667	65	Female	No	I	Adenocarcinoma	Moderately differentiated
A239	GSK	LIVING	6.333333333	53	Male	No	I	Adenocarcinoma	Moderately differentiated
A250	GSK	LIVING	33.4	55	Male	Yes	I	Adenocarcinoma	Moderately differentiated
A240	GSK	LIVING	31.5	50	Male	Yes	I	Adenocarcinoma	Poorly differentiated
A249	GSK	LIVING	31.5	53	Female	No	II	Adenocarcinoma	NA
A322	GSK	DECEASED	23.13333333	70	Female	No	I	Adenocarcinoma	Moderately differentiated
A306	GSK	LIVING	30.83333333	55	Male	Yes	I	Adenocarcinoma	Moderately differentiated
A302	GSK	LIVING	29.8	68	Female	No	I	Adenocarcinoma	Moderately differentiated
A323	GSK	LIVING	29.13333333	63	Male	No	II	Adenocarcinoma	Moderately differentiated
A307	GSK	DECEASED	26.16666667	56	Male	No	III	Adenocarcinoma	Moderately differentiated
A380	GSK	LIVING	33.03333333	61	Female	No	I	Adenocarcinoma	Moderately differentiated
A315	GSK	LIVING	30	64	Female	No	III	Adenocarcinoma	Well to Moderately differentiated
A377	GSK	LIVING	26.4	71	Female	No	I	Adenocarcinoma	Moderately differentiated
A375	GSK	LIVING	28.63333333	60	Female	No	I	Adenocarcinoma	Moderately differentiated
A425	GSK	LIVING	28.73333333	56	Female	Yes	NA	Adenocarcinoma	Moderately differentiated
A316	GSK	LIVING	30.73333333	77	Female	No	I	Adenocarcinoma	Moderately differentiated
A379	GSK	LIVING	28.23333333	62	Male	Yes	III	Adenocarcinoma	Moderately differentiated
A483	GSK	LIVING	129.2666667	58	Female	No	III	Adenocarcinoma	Well differentiated
A484	GSK	LIVING	118.9	57	Female	No	III	Adenocarcinoma	Moderately differentiated
A485	GSK	LIVING	118.1333333	72	Female	No	I	Adenocarcinoma	Well differentiated
A486	GSK	DECEASED	85.26666667	45	Female	No	I	Adenocarcinoma	Well differentiated
A488	GSK	DECEASED	50.9	60	Female	No	III	Adenocarcinoma	Moderately differentiated
A489	GSK	DECEASED	16.16666667	72	Male	Yes	III	Adenocarcinoma	Moderately differentiated
A490	GSK	LIVING	99.36666667	59	Male	No	II	Adenocarcinoma	Moderately differentiated
A492	GSK	DECEASED	55.66666667	47	Male	Yes	I	Adenocarcinoma	Moderately differentiated
A493	GSK	DECEASED	48.36666667	58	Female	No	I	Adenocarcinoma	Moderately differentiated
A494	GSK	LIVING	88.86666667	67	Female	No	I	Adenocarcinoma	Well differentiated
A495	GSK	LIVING	92.46666667	53	Male	No	III	Adenocarcinoma	Moderately differentiated
A496	GSK	LIVING	92.9	53	Female	No	III	Adenocarcinoma	Moderately differentiated
A497	GSK	DECEASED	43.43333333	45	Female	No	III	Adenocarcinoma	Moderately differentiated
A499	GSK	LIVING	84.2	70	Male	Yes	I	Adenocarcinoma	Moderately differentiated
A500	GSK	DECEASED	114.9	70	Female	No	I	Adenocarcinoma	Moderately differentiated
A501	GSK	DECEASED	15.23333333	68	Female	No	I	Adenocarcinoma	Poorly differentiated
A502	GSK	LIVING	74.23333333	54	Female	No	I	Adenocarcinoma	NA
A503	GSK	DECEASED	34.83333333	60	Female	No	I	Adenocarcinoma	Moderately to Poorly differentiated
A504	GSK	LIVING	29.53333333	72	Female	No	I	Adenocarcinoma	Well differentiated
A505	GSK	DECEASED	35.16666667	41	Female	No	II	Adenocarcinoma	Moderately differentiated
A295	GSK	LIVING	52.96666667	74	Female	No	I	Adenocarcinoma	Moderately differentiated
A152	GSK	LIVING	80.5	59	Female	No	IV	Adenocarcinoma	Poorly differentiated
A015	GSK	DECEASED	28.73333333	69	Female	No	II	Adenocarcinoma	Moderately differentiated
A062	GSK	LIVING	53.46666667	74	Male	No	IV	Adenocarcinoma	Moderately to Poorly differentiated
A037	GSK	LIVING	50.33333333	66	Female	No	II	Adenocarcinoma	Moderately differentiated
A066	GSK	LIVING	51.33333333	72	Female	No	I	Adenocarcinoma	Moderately differentiated
A310	GSK	LIVING	28.36666667	67	Male	No	I	Adenocarcinoma	Well differentiated
A320	GSK	LIVING	28.03333333	75	Female	Yes	I	Adenocarcinoma	Moderately differentiated
A426	GSK	LIVING	26.96666667	65	Female	No	I	Adenocarcinoma	Moderately differentiated
A381	GSK	LIVING	27.43333333	66	Male	Yes	I	Adenocarcinoma	Moderately differentiated
A428	GSK	LIVING	21.86666667	66	Male	No	II	Adenocarcinoma	Moderately differentiated
A430	GSK	DECEASED	13.13333333	70	Female	No	III	Adenocarcinoma	Moderately differentiated
A432	GSK	LIVING	27.9	64	Female	No	I	Adenocarcinoma	Moderately differentiated
A434	GSK	LIVING	26.83333333	67	Female	No	II	Adenocarcinoma	Moderately differentiated
A435	GSK	LIVING	26.53333333	68	Female	No	II	Adenocarcinoma	Moderately differentiated
A507	GSK	DECEASED	40.5	72	Female	No	I	Adenocarcinoma	Well to Moderately differentiated
A508	GSK	DECEASED	22.96666667	71	Male	Yes	III	Adenocarcinoma	Poorly differentiated
A509	GSK	LIVING	59.46666667	75	Male	Yes	II	Adenocarcinoma	Moderately differentiated
A063	GSK	LIVING	51.13333333	70	Female	No	I	Adenocarcinoma	Moderately differentiated
A130	GSK	LIVING	47.36666667	66	Female	No	I	Adenocarcinoma	Moderately differentiated
A168	GSK	LIVING	21.73333333	64	Male	No	III	Adenocarcinoma	Moderately differentiated
A433	GSK	LIVING	27.76666667	64	Female	Yes	II	Adenocarcinoma	Poorly differentiated
A513	GSK	DECEASED	7.6	65	Male	Yes	IV	Adenocarcinoma	NA
A112	GSK	LIVING	49.06666667	61	Female	No	I	Adenocarcinoma	Moderately differentiated
A114	GSK	LIVING	46.56666667	61	Female	No	II	Adenocarcinoma	Moderately differentiated
A111	GSK	LIVING	48.76666667	62	Female	No	I	Adenocarcinoma	Moderately differentiated
A110	GSK	DECEASED	17.2	72	Male	Yes	II	Adenocarcinoma	Moderately differentiated
A124	GSK	LIVING	46.46666667	68	Male	Yes	I	Adenocarcinoma	Moderately differentiated
A126	GSK	DECEASED	27.6	68	Male	Yes	II	Adenocarcinoma	Moderately differentiated
A511	GSK	LIVING	29.66666667	63	Male	No	II	Adenocarcinoma	Poorly differentiated
A512	GSK	LIVING	21.66666667	55	Male	No	I	Adenocarcinoma	Moderately differentiated
A514	GSK	LIVING	25.06666667	56	Female	No	I	Adenocarcinoma	Moderately differentiated
A517	GSK	LIVING	24.76666667	68	Female	No	III	Adenocarcinoma	Moderately differentiated
A510	GSK	LIVING	23.5	73	Male	No	III	Adenocarcinoma	Moderately differentiated
A524	GSK	DECEASED	5.633333333	73	Male	Yes	I	Adenocarcinoma	Moderately differentiated
A522	GSK	LIVING	21.3	63	Male	Yes	I	Adenocarcinoma	NA
A521	GSK	LIVING	22.43333333	55	Female	No	I	Adenocarcinoma	Moderately differentiated
A519	GSK	LIVING	24.06666667	69	Female	Yes	III	Adenocarcinoma	Moderately differentiated
A534	GSK	LIVING	21.2	77	Female	No	I	Adenocarcinoma	Moderately differentiated
A530	GSK	LIVING	20.3	72	Female	Yes	I	Adenocarcinoma	NA
A532	GSK	LIVING	17.8	62	Male	Yes	I	Adenocarcinoma	Moderately differentiated
A538	GSK	LIVING	22.3	59	Female	No	I	Adenocarcinoma	Moderately differentiated
A537	GSK	DECEASED	18.1	79	Male	Yes	III	Adenocarcinoma	Poorly differentiated
